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LETTERS TO THE EDITOR 
Natural Killer Cells Express the CD 16 Antigen 
To the Editor: 
We read with great interest and benefit th e recent article from 
Kohchi yama et al [1] conce rnin g immunohistologic studies of 
squamous cell ca rcinoma (SCC). 
The authors suggest a possible parti cipation of Leu-7+ cells as 
antitumo r effector cells against SCc. Moreover, they state that 
anti-Leu-7 monoclonal antibody identifies natural killer (NK) cells. 
This is par tl y in contras t with recent reports from us and o ther 
investigato rs. In fact, light microscopy [2,3] and electron mi-
croscopy [4,5] double-labeling procedures provided evidence for 
the existence of three discrete NK cell subpopulations, i. e., Leu-
r, 11 - , Leu-7 +, 11 +, and Leu-7 - , 11 + cells. The Leu-7 - , 11 + sub-
set possesses the most potent NK cell function capability, whereas 
the Leu-7 +, 11 - subset demonstrates the lowest NK activity [2,3,5]. 
Furthermore, NK cells exp ressing the CD16 (Leu-ll) antigen 
display a different ultras tructural pattern in comparison to Leu-
7 +,11 - cells [6J . Finally , the HNK-l (Leu-7) anti gen is co ex-
pressed by the maj ority of T8, C D11 + suppressor cells [7] . 
The authors describe both OKT8+ and Leu-r cells in close 
associati on with individual cancer cells. Are they the same cells? 
Unfortunately , by using a single labeling, Kohchiyama et al could 
not well characterize the immunophenotype of their Leu-7 + cells. 
In conclusion, it would be necessary to perform double label-
ings to verify to which cell subpopulations the described Leu-7 + 
cells belong. Investigations performed by Kohchiyama et al [1] 
are not sufficient to defin e Leu-7 + cells as NK cells. 
Gian Carlo Manara, M .D. 
Corrado Ferrari, M .D. 
Giuseppe De Panfilis , M .D. 
Department of Dermatology 
University of Parma 
Parma , Italy 
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REPLY 
The authors appreciate Dr. Manara's comments. As was pointed 
out above, we were not able to characterize the Leu-7 + cell sub-
populations, and the possibility cannot fully be denied that the 
OKT8 + cell s also expressed the Leu7 antigen . Although both 
O KT8 + and Leu-7 + cells could be seen in close association with 
individual cancer cells, a difference could be seen in their distri-
bution by careful observation of serial sections. So we believe 
that the OKT8 + and Leu-7 + cells were not the same cells. We 
intend to verify the Leu-7 + cell subpopulations in lesions ofSCC 
in the future. 
Akira Kohchiya ma, M .D. 
Kawasaki Medical School 
Okayama, Japan 
Keratinocyte Grafting: Covering of Skin Defects by Separated Autologous 
Keratinocytes in a Fibrin Net 
To the Editor: 
T he clinica l application of autografts by cultured keratinocytes 
was first demonstra ted in 1981 [1]. We read with great interes t 
the article by T akashima et al in the May 1986 issue . The authors 
reported in connection with an animal model that freshly isolated 
epidermal cells transplanted onto full-thickness wound beds form ed 
a multilayered epithelial structure after 10 days [2]. On the basis 
of this observation, we have developed a method, keratinocyte 
graftin g (KG), for the autotransplantation of skin defects with 
living keratinocytes. A fibrin net is an important element in the 
healing of wounds, as it provides a provisional matrix fo r epi-
dermal cell migration during reepithelializa tion [3,4]. Keratino-
cyte graftin g was therefore carried out with an artifi cial fibrin net 
containing living kera tinocytes. 
Epidermal cells were separated from a fresh surgical skin spec-
imen of the patient by the trypsin digestion method described by 
Eisinger et al [5]. The cells were washed 3 times in phosphate 
basal solution (PBS; 0.05 M phosphate buffer , pH 7.2, and 0. 1 M 
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